Abiopharma

Mahadevia Ankit 🔴 sold 6.6K shares of Spero Therapeutics, Inc. (SPRO) at $1.97 Transaction Date: Aug 28, 2025 | Filing ID: 112661

Enanta Pharmaceuticals Announces the Passing of its Beloved and Respected Longtime Chief Financial and Administrative Officer Paul J. Mellett Jr.

Aclarion Appoints Greg Gould as Chief Financial Officer

Employee Stock Option/ Share Scheme: NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) - OTHER ISSUE OF SECURITIES

Hyphens Notification - Evolve Capitals Equity Research - 1H25: Near Term Performance Likely to Remain Subdued Before Modest Recovery

Evolve Capital’s Equity Research – Near Term Performance Likely to Remain Subdued Before Modest Recovery

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT 2016

ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Harnessing Human Potential to Power Vaccine Innovation

Gamescom 2025 Recap: Biggest Announcements and Highlights

AI in Game Design: Smarter NPCs, Dynamic Storytelling, and Procedural Worlds

Happening Today: Your 30-Minute CAHPS Insider Live Update

NUTX Investors Have Opportunity to Lead Nutex Health Inc. Securities Fraud Lawsuit with the Schall Law Firm

NASDAQ symbol attribute type Security_Name was changed. Previous value: Connect Biopharma Holdings Limited - American Depositary Shares. New value: Connect Biopharma Holdings Limited - Ordinary Shares.

REPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Fraud Lawsuit with the Schall Law Firm